Meyka Pro banner
Novo Nordisk A/S

Stay Updated with the Latest Novo Nordisk A/S NOV.DE News in Real Time

Find NOV.DE news now at Meyka AI. Stay informed with the latest Novo Nordisk A/S stocks updates, including price news, market analysis, and expert insights.

NOV.DEXETRA
HealthcareDrug Manufacturers - General
41.27
0.96(2.38%)
German Market is Open · 14:25
Clocks Fall Back November 1, 2026: Senate Debates Permanent Daylight Saving Time
📅 11 days ago

Clocks Fall Back November 1, 2026: Senate Debates Permanent Daylight Saving Time

Clocks fall back November 1, 2026. Trump urges Senate to pass Sunshine Protection Act and make daylight saving time permanent, but opposition from GOP senators threatens the bill.

Read more 12
Amazon Pharmacy Expands $50/Month GLP-1 Access for Medicare Patients, Targets 4,500 US Cities by 2026
📅 20 days ago

Amazon Pharmacy Expands $50/Month GLP-1 Access for Medicare Patients, Targets 4,500 US Cities by 2026

Amazon Pharmacy announced Thursday, August 6, 2026, that it joined the federal Medicare GLP-1 Bridge Program. Eligible Medicare Part D patients can now access GLP-1 medications for a flat $50 monthly copay. The program covers Wegovy, Zepbound, and Foundayo, with free home delivery included. Amazon Pharmacy currently serves over 3,100 US cities, expanding toward 4,500…

Read more 12
TGA Warns GLP-1 Drugs Linked to Rare Eye Blindness July 25
📅 1 month ago

TGA Warns GLP-1 Drugs Linked to Rare Eye Blindness July 25

Australia’s TGA warns GLP-1 drugs like Ozempic and Mounjaro linked to 36 cases of NAION, a rare eye disorder causing permanent blindness. No treatment available.

Read more 12
TGA Warns GLP-1 Drugs Like Ozempic Linked to Rare Eye Blindness July 25
📅 1 month ago

TGA Warns GLP-1 Drugs Like Ozempic Linked to Rare Eye Blindness July 25

Australia’s TGA warns GLP-1 drugs like Ozempic may cause NAION, a rare eye disorder leading to blindness. 36 cases reported. No treatment available. Patients urged to seek urgent medical attention if vision changes occur.

Read more 12
GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24
📅 1 month ago

GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24

New BMJ study finds GLP-1 weight loss drugs like Ozempic and Mounjaro linked to 37-68% higher hair loss risk. Researchers say the absolute risk remains low and hair loss is typically reversible.

Read more 12
Eternal (NSE: ETERNAL) Shares Jump 4% After Strong Q1 Results as Analysts Turn Bullish on FY27
📅 1 month ago

Eternal (NSE: ETERNAL) Shares Jump 4% After Strong Q1 Results as Analysts Turn Bullish on FY27

Eternal shares jumped as much as 4.5% on July 23, 2026, hitting an intraday high of ₹296.15. The Zomato and Blinkit parent posted Q1 FY27 revenue of ₹20,211 crore, up 182% year-on-year. Consolidated net profit climbed 268% to ₹92 crore, though it fell 47% sequentially. Blinkit turned EBITDA-positive for the first time, swinging from a…

Read more 12
Novo Nordisk (NYSE: NVO) Sues Eli Lilly (NYSE: LLY) Over Allegedly Misleading GLP-1 Drug Advertising
📅 1 month ago

Novo Nordisk (NYSE: NVO) Sues Eli Lilly (NYSE: LLY) Over Allegedly Misleading GLP-1 Drug Advertising

On 21 July 2026, Novo Nordisk (NYSE: NVO) filed a lawsuit against Eli Lilly (NYSE: LLY), accusing its rival of misleading consumers through advertising that compares their blockbuster GLP-1 weight-loss drugs. The legal dispute comes as demand for obesity treatments keeps rising and competition between the two drugmakers becomes more intense.  The outcome could affect…

Read more 12
Warren Buffett’s 2034 Donation Plan Could Leave Berkshire Hathaway Stock 22% Undervalued
📅 1 month ago

Warren Buffett’s 2034 Donation Plan Could Leave Berkshire Hathaway Stock 22% Undervalued

On July 14, 2026, Warren Buffett announced that he intends to donate all of his remaining Berkshire Hathaway shares by December 31, 2034. The decision extends one of the largest charitable commitments ever made by an individual.  It has also renewed interest in Berkshire Hathaway’s valuation and whether the stock is trading below its estimated…

Read more 12
Esper: Iran Rushing Negotiations Before Midterms as U.S. Strikes Mount
📅 2 months ago

Esper: Iran Rushing Negotiations Before Midterms as U.S. Strikes Mount

Former Defense Secretary Mark Esper says Iran is racing to negotiate before midterms. The U.S. struck 90 Iranian targets Wednesday after Iran attacked commercial ships and U.S. bases.

Read more 12

NOV.DE News FAQ